PRMT1 gene expression is substantially higher in breast tumor samples than in healthy breast tissues, and several studies evidence its role in regulating the metastatic potential of breast cancer, as well as therapy efficacy [11,12]. This evidence concerns the gene PRMT1 and breast cancer.